UBS raised the firm’s price target on Veracyte (VCYT) to $46 from $43 and keeps a Buy rating on the shares post the earnings report.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter